The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Mar. 10, 2009
Filed:
Sep. 07, 2005
Dong-yeon Kim, Seoul, KR;
Dae-jin Cho, Seoull, KR;
Gong-yeal Lee, Gyeonggi-Do, KR;
Hong-youb Kim, Seoul, KR;
Seok-hun Woo, Gyeonggi-do, KR;
Yong-seok Kim, Gyeonggi-Do, KR;
Sun-ahe Lee, Gyeonggi-Do, KR;
Byoung-cheol Han, Incheon, KR;
Dong-Yeon Kim, Seoul, KR;
Dae-Jin Cho, Seoull, KR;
Gong-Yeal Lee, Gyeonggi-Do, KR;
Hong-Youb Kim, Seoul, KR;
Seok-Hun Woo, Gyeonggi-do, KR;
Yong-Seok Kim, Gyeonggi-Do, KR;
Sun-Ahe Lee, Gyeonggi-Do, KR;
Byoung-Cheol Han, Incheon, KR;
Il-Yang Pharm. Co., Ltd., Gyeonggi-do, KR;
Abstract
The present invention relates to a novel N-phenyl-2-pyrimidine-amine derivative represented by the above formula (1) and its salt showing a superior effect on cancer in warm-blooded animals, such as lung cancer, gastric cancer, colon cancer, pancreatic cancer, hepatoma, prostatic cancer, breast cancer, chronic or acute leukemia, hematologic malignancy, encephalophyma, bladder cancer, rectal cancer, cervical cancer, lymphoma, etc. The present invention also relates to a process for preparing the compound, and to a pharmaceutical composition for the treatment of the above various diseases, which comprises an effective amount of the compound as an active ingredient together with pharmaceutically acceptable inert carriers.